Woodline Partners LP - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 51 filers reported holding SIGILON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$193,000
-47.4%
34,2000.0%0.00%
-57.1%
Q2 2021$367,000
-52.0%
34,2000.0%0.01%
-58.8%
Q1 2021$764,000
-51.0%
34,200
+5.4%
0.02%
-58.5%
Q4 2020$1,558,00032,4340.04%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$28,622,0000.44%
HARBOURVEST PARTNERS LLC 740,740$2,044,0000.26%
SOUNDMARK WEALTH MANAGEMENT, LLC 25,555$71,0000.05%
Artal Group S.A. 276,000$762,0000.02%
Choate Investment Advisors 66,666$184,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$552,0000.01%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$4,099,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 142,781$394,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$1,407,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 234,153$646,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders